JM
Jan Mattsson
Board Member at Toleranzia
View Jan's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Board Member
Sep 2019 - Present · 5 years and 3 months
2008 - Dec 2023 · 15 years and 11 months
Chief Scientific Officer & Managing Director, Co-Founder
Jan 2019 - Dec 2023 · 4 years and 11 months
Board Member Albireo Ab
2008 - 2023 · 15 years
Company Details
2-10 Employees
Toleranzia develops protein-based antigen-specific immune tolerogens to cure patients with autoimmune diseases. The drugs have the potential to become the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. The company has a lead project in myasthenia gravis as well as a second project in ANCA vasculitis. Toleranzia is listed on the Nasdaq First North Growth Market and backed by strongly committed renowned specialist investors.
Year Founded
2011
Social Media
LinkedinTwitter
Industry
Pharmaceutical Manufacturing, Natural science research establishments, Research and testing, IT, Internet, R&D, Medical technology research and development
HQ Location
Arvid Wallgrens backe 20 Gothenburg, 411 26, SE
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Jan Mattsson in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.